Journal of Renal Nutrition
Volume 16, Issue 2 , Pages 100-118 , April 2006

Disordered Mineral Metabolism and Vascular Calcification in Nondialyzed Chronic Kidney Disease Patients

  • Rajnish Mehrotra, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Rajnish Mehrotra, MD, 1124 West Carson Street, Torrance, CA 90502

References 

  1. National Kidney Foundation . K/DOQI Clinical practice guidelines for chronic kidney disease (Evaluation, classification and stratification) . Am J Kidney Dis . 2002;39:S1–S266
  2. National Kidney Foundation . K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease . Am J Kidney Dis . 2003;42:S1–S202
  3. Lowrie EG , Lew N . Death risk in hemodialysis patients (The predictive value of commonly measured variables and an evaluation of death rate differences between facilities) . Am J Kidney Dis . 1990;15:458–482
  4. Block GA , Hulbert-Shearon TE , Levin NW , et al.   Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients (A national study) . Am J Kidney Dis . 1998;31:607–617
  5. Ganesh SK , Stack AG , Levin NW , et al.   Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients . J Am Soc Nephrol . 2001;12:2131–2138
  6. Block GA , Klassen PS , Lazarus JM , et al.   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis . Am Soc Nephrol . 2004;15:2208–2218
  7. Stevens LA , Djudjev O , Cardew S , et al.   Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality (Evidence for the complexity of the association between mineral metabolism and outcomes) . J Am Soc Nephrol . 2004;15:770–779
  8. Young EW , Albert JM , Satayathum S , et al.   Predictors and consequences of altered mineral metabolism (The Dialysis Outcomes and Practice Patterns Study) . Kidney Int . 2005;67:1179–1187
  9. Slinin Y , Foley RN , Collins AJ . Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients (The USRDS waves 1, 3, and 4 study) . J Am Soc Nephrol . 2005;16:1788–1793
  10. Diaz-Buxo JA , Lowrie EG , Lew NL , et al.   Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance . Am J Kidney Dis . 1999;33:523–534
  11. Virchow R . Kall metastasen . Virchow Arch . 1855;8:103–113
  12. Mulligan RM . Metastatic calcification . Arch Pathol . 1947;43:177–230
  13. Parfitt AM , Massry SG , Winfield AC , et al.   Disordered calcium and phosphorus metabolism during maintenance hemodialysis. Correlation of clinical, roentgenographic and biochemical changes . Am J Med . 1971;51:319–330
  14. Meema HE , Oreopoulos DG , deVeber GA . Arterial calcifications in severe chronic renal disease and their relationship to dialysis treatment, renal transplant, and parathyroidectomy . Radiology . 1976;121:315–321
  15. Kuzela DC , Huffer WE , Conger JD , et al.   Soft tissue calcification in chronic dialysis patients . Am J Pathol . 1977;86:403–424
  16. Raggi P , Boulay A , Chasan-Taber S , et al.   Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? . J Am Coll Cardiol . 2002;39:695–701
  17. Milliner DS , Zinsmeister AR , Lieberman E , et al.   Soft tissue calcification in pediatric patients with end-stage renal disease . Kidney Int . 1990;38:931–936
  18. Kimura K , Saika Y , Otani H , et al.   Factors associated with calcification of the abdominal aorta in hemodialysis patients . Kidney Int . 1999;56(suppl 71):S238–S241
  19. Oh J , Wunsch R , Turzer M , et al.   Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure . Circulation . 2002;106:100–105
  20. Shigematsu T , Kono T , Satoh K , et al.   Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients . Nephrol Dial Transplant . 2003;18(suppl 3):86–89
  21. Schmid K , McSharry WO , Pameijer CH , Binette JP . Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta . Atherosclerosis . 1980;37:199–210
  22. Bostrom K , Watson KE , Horn S , et al.   Bone morphogenetic protein expression in human atherosclerotic lesions . J Clin Invest . 1993;91:1800–1809
  23. Shanahan CM , Cary NR , Metcalfe JC , et al.   High expression of genes for calcification-regulating proteins in human atherosclerotic plaques . J Clin Invest . 1994;93:2393–2402
  24. Shanahan CM , Cary NR , Salisbury JR , et al.   Medial localization of mineralization-regulating proteins in association with Monckeberg’s sclerosis (Evidence for smooth muscle cell-mediated vascular calcification) . Circulation . 1999;100:2168–2176
  25. Bostrom K . Insights into the mechanism of vascular calcification . Am J Cardiol . 2001;88:20E–22E
  26. Wallin R , Wajih N , Greenwood GT , et al.   Arterial calcification (A review of mechanisms, animal models, and the prospects for therapy) . Med Res Rev . 2001;21:274–301
  27. Moe SM , O’Neill KD , Duan D , et al.   Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins . Kidney Int . 2002;61:638–647
  28. Moe SM , Duan D , Doehle BP , et al.   Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels . Kidney Int . 2003;63:1003–1011
  29. Jono S , McKee MD , Murry CE , et al.   Phosphate regulation of vascular smooth muscle cell calcification . Circ Res . 2000;87:E10–E17
  30. Yang H , Curinga G , Giachelli CM . Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro . Kidney Int . 2004;66:2293–2299
  31. Reynolds JL , Joannides AJ , Skepper JN , et al.   Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations (A potential mechanism for accelerated vascular calcification in ESRD) . J Am Soc Nephrol . 2004;15:2857–2867
  32. Blacher J , Guerin AP , Pannier B , et al.   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease . Hypertension . 2001;38:938–942
  33. Matsuoka M , Iseki K , Tamashiro M , et al.   Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis . Clin Exp Nephrol . 2004;8:54–58
  34. Chertow GM , Burke SK , Raggi P . Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients . Kidney Int . 2002;62:245–252
  35. Asmus HG , Braun J , Krause R , et al.   Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density . Nephrol Dial Transplant . 2005;20:1653–1661
  36. Merjanian R , Budoff M , Adler S , et al.   Coronary Artery, Aortic Wall and Valvular Calcification in Nondialyzed Patients With Type 2 Diabetes and Renal Disease . Kidney Int . 2003;64:263–271
  37. Mehrotra R , Budoff MJ , Christenson P , et al.   Determinants of coronary artery calcification in diabetic patients with and without nephropathy . Kidney Int . 2004;66:2022–2031
  38. Fox CS , Larson MG , Keyes MJ , et al.   Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease (The Framingham Heart Study) . Kidney Int . 2004;66:2017–2021
  39. Kestenbaum B , Sampson JN , Rudser KD , et al.   Serum phosphate levels and mortality risk among people with chronic kidney disease . J Am Soc Nephrol . 2005;16:520–528
  40. Madsen S , Olgaard K , Ladefoged J . Renal handling of phosphate in relation to serum parathyroid hormone levels . Acta Med Scand . 1976;200:7–10
  41. Tougaard L , Sorensen E , Christensen MS , et al.   Bone composition and parathyroid function in chronic renal failure . Acta Med Scand . 1977;202:33–38
  42. Tessitore N , Venturi A , Adami S , et al.   Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure . Miner Electrolyte Metab . 1987;13:38–44
  43. St John A , Thomas MB , Davies CP , et al.   Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure . Nephron . 1992;61:422–427
  44. Messa P , Mioni G , Turrin D , Guerra UP . The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function . Nephrol Dial Transplant . 1995;10:2259–2265
  45. DeBoer IH , Gorodetskaya I , Young B , et al.   The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease . J Am Soc Nephrol . 2002;13:2762–2769
  46. Coburn JW , Popovtzer MM , Massry SG , et al.   The physicochemical state and renal handling of divalent ions in chronic renal failure . Arch Intern Med . 1969;124:302–311
  47. Massry SG , Coburn JW , Lee DB , et al.   Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects . Ann Intern Med . 1973;78:357–364
  48. Malluche HH , Ritz E , Lange HP , et al.   Bone histology in incipient and advanced renal failure . Kidney Int . 1976;9:355–362
  49. Christensen MS , Nielsen HE . Parathyroid function after renal transplantation (Interrelationships between renal function, serum calcium and serum parathyroid hormone in normocalcemic long-term survivors) . Clin Nephrol . 1977;8:472–476
  50. vonLilienfeld-Toal H , Gerlach I , Klehr HU , et al.   Immunoreactive parathyroid hormone in early and advanced renal failure . Nephron . 1982;31:116–122
  51. Pitts TO , Piraino BH , Mitro R , et al.   Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure . J Clin Endocrinol Metab . 1988;67:876–881
  52. Reichel H , Deibert B , Schmidt-Gayk H , et al.   Calcium metabolism in early chronic renal failure (Implications for the pathogenesis of hyperparathyroidism) . Nephrol Dial Transplant . 1991;6:162–169
  53. Saha H . Calcium and vitamin D homeostasis in patients with heavy proteinuria . Clin Nephrol . 1994;41:290–296
  54. Fajtova VT , Sayegh MH , Hickey N , et al.   Intact parathyroid hormone levels in renal insufficiency . Calcif Tissue Int . 1995;57:329–335
  55. Martinez I , Saracho R , Montenegro J , et al.   The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure . Am J Kidney Dis . 1997;29:496–502
  56. Rix M , Andreassen H , Eskildsen P , et al.   Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure . Kidney Int . 1999;56:1084–1093
  57. Ishimura E , Nishizawa Y , Inaba M , et al.   Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure . Kidney Int . 1999;55:1019–1027
  58. Hsu CY , Chertow GM . Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency . Nephrol Dial Transplant . 2002;17:1419–1425
  59. Coburn JW , Koppel MH , Brickman AS , et al.   Study of intestinal absorption of calcium in patients with renal failure . Kidney Int . 1973;3:264–272
  60. Cheung AK , Manolagas SC , Catherwood BD , et al.   Determinants of serum 1,25(OH)2D levels in renal disease . Kidney Int . 1983;24:104–109
  61. McGonigle RJ , Wallin JD , Husserl F , et al.   Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure . J Lab Clin Med . 1984;104:1016–1026
  62. Coen G , Mazzaferro S , Costantini S , et al.   Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment . Miner Electrolyte Metab . 1989;15:295–302
  63. Yumita S , Suzuki M , Akiba T , et al.   Levels of serum 1,25 (OH)2D in patients with pre-dialysis chronic renal failure . Tohuku J Exp Med . 1996;180:45–56
  64. Kates DM , Sherrard DJ , Andress DL . Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure . Am J Kidney Dis . 1997;30:809–813
  65. Marco MP , Martinez I , Amoedo ML , et al.   Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients . Kidney Int . 1999;56:1349–1353
  66. Inaba M , Nagasue K , Okuno S , et al.   Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus . Am J Kidney Dis . 2002;39:1261–1269
  67. Mehrotra R , Supasyndh O , Berman N , et al.   Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake . J Ren Nutr . 2004;14:134–142
  68. Lu KC , Shieh SD , Chyr SH , et al.   Serum osteocalcin and vitamin D in postmenopausal diabetic azotemics . Diabetes Res . 1993;22:97–104
  69. Arnaud CD . Hyperparathyroidism and renal failure . Kidney Int . 1973;4:89–95
  70. Perwad F , Azam N , Zhang MY , et al.   Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25(OH)2D metabolism in mice . Endocrinology . 2005;146:5358–5364
  71. Gutierrez O , Isakova T , Rhee E , et al.   Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease . J Am Soc Nephrol . 2005;16:2205–2215
  72. Bolton WK . Renal physicians association clinical practice guideline: Appropriate patient preparation for renal replacement therapy: Guideline number 3 . J Am Soc Nephrol . 2003;14:1406–1410
  73. Mason RS , Lissner D , Wilkinson M , et al.   Vitamin D metabolites and their relationship to azotaemic osteodystrophy . Clin Endocrinol (Oxf) . 1980;13:375–385
  74. Goldstein DA , Oda Y , Kurokawa K , et al.   Blood levels of 25-hydroxyvitamin D in nephrotic syndrome. Studies in 26 patients . Ann Intern Med . 1977;87:664–667
  75. Auwerx J , DeKeyser L , Bouillon R , et al.   Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome . Nephron . 1986;42:231–235
  76. Goldstein DA , Haldimann B , Sherman D , et al.   Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function . J Clin Endocrinol Metab . 1981;52:116–121
  77. Gonzalez EA , Sachdeva A , Oliver DA , et al.   Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study . Am J Nephrol . 2004;24:503–510
  78. Lambert PW , DeOreo PB , Fu IY , et al.   Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome . Metab Bone Dis Relat Res . 1982;4:7–15
  79. Barragry JM , France MW , Carter ND , et al.   Vitamin-D metabolism in nephrotic syndrome . Lancet . 1977;2(8039):629–632
  80. Koenig KG , Lindberg JS , Zerwekh JE , et al.   Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease . Kidney Int . 1992;41:161–165
  81. Bordier PJ , Marie PJ , Arnaud CD . Evolution of renal osteodystrophy (Correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol) . Kidney Int Suppl . 1975;2:102–112
  82. Suzuki M , Hirasawa Y . Renal osteodystrophy in early chronic renal failure . Contrib Nephrol . 1980;22:28–38
  83. Bedani PL , Tamarozzi R , Pinna L , et al.   Early skeletal changes of the hand phalanges in patients with chronic renal failure . Int J Artif Organs . 1985;8:325–330
  84. Hamdy NA , Kanis JA , Beneton MN , et al.   Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure . BMJ . 1995;310:358–363
  85. Coen G , Mazzaferro S , Ballanti P , et al.   Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure (A cross-sectional study) . Nephrol Dial Transplant . 1996;11:813–819
  86. Mora-Palma FJ , Ellis HA , Cook DB , et al.   Osteomalacia in patients with chronic renal failure before dialysis or transplantation . Q J Med . 1983;52:332–348
  87. Cohen-Solal ME , Sebert JL , Boudailliez B , et al.   Nonaluminic adynamic bone disease in nondialyzed uremic patients (A new type of osteopathy due to overtreatment?) . Bone . 1992;13:1–5
  88. Hutchison AJ , Whitehouse RW , Boulton HF , et al.   Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease . Kidney Int . 1993;44:1071–1077
  89. Hernandez D , Concepcion MT , Lorenzo V , et al.   Adynamic bone disease with negative aluminium staining in predialysis patients (Prevalence and evolution after maintenance dialysis) . Nephrol Dial Transplant . 1994;9:517–523
  90. Nielsen SP , Sorensen OH , Lund B , et al.   Calcium metabolism in patients with chronic nondialytic renal disease . Calcif Tissue Res . 1976;21:202–209
  91. Madsen S , Olgaard K , Ladefoged J . Degree and course of skeletal demineralization in patients with chronic renal insufficiency . Scand J Urol Nephrol . 1978;12:243–249
  92. Rickers H , Christiansen C , Christensen P , et al.   Serum concentrations of vitamin D metabolites in different degrees of impaired renal function. Estimation of renal and extrarenal secretion rate of 24,25-dihydroxyvitamin D . Nephron . 1985;39:267–271
  93. Bianchi ML , Colantonio G , Montesano A , et al.   Bone mass status in different degrees of chronic renal failure . Bone . 1992;13:225–228
  94. Boling EP , Primavera C , Friedman G , et al.   Noninvasive measurements of bone mass in adult renal osteodystrophy . Bone . 1993;14:409–413
  95. Przedlacki J , Manelius J , Huttunen K . Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure . Nephron . 1995;69:433–437
  96. Hsu CY , Cummings SR , McCulloch CE , et al.   Bone mineral density is not diminished by mild to moderate chronic renal insufficiency . Kidney Int . 2002;61:1814–1820
  97. Mehrotra R , Kopple JD , Wolfson M . Metabolic acidosis in maintenance dialysis patients (Clinical considerations) . Kidney Int Suppl . 2003;88:S13–S25
  98. Fine A , Fleming S , Leslie W . Calciphylaxis presenting with calf pain and plaques in four continuous ambulatory peritoneal dialysis patients and in one predialysis patient . Am J Kidney Dis . 1995;25:498–502
  99. Bleyer AJ , Choi M , Igwemezie B , et al.   A case control study of proximal calciphylaxis . Am J Kidney Dis . 1998;32:376–383
  100. Coates T , Kirkland GS , Dymock RB , et al.   Cutaneous necrosis from calcific uremic arteriolopathy . Am J Kidney Dis . 1998;32:384–391
  101. Smiley CM , Hanlon SU , Michel DM . Calciphylaxis in moderate renal insufficiency (Changing disease concepts) . Am J Nephrol . 2000;20:324–328
  102. Pliquett RU , Schwock J , Paschke R , et al.   Calciphylaxis in chronic, nondialysis-dependent renal disease . BMC Nephrol . 2003;4:8
  103. Schoppet M , Al-Fakhri N , Franke FE , et al.   Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Monckeberg’s sclerosis and atherosclerosis . J Clin Endocrinol Metab . 2004;89:4104–4112
  104. O’Rourke RA , Brundage BH , Froelicher VF , et al.   American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease . Circulation . 2000;102:126–140
  105. Sharples EJ , Pereira D , Summers S , et al.   Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients . Am J Kidney Dis . 2004;43:313–319
  106. Budoff MJ . Prognostic value of coronary artery calcification . JCOM . 2001;8:42–48
  107. Greenland P , LaBree L , Azen SP , et al.   Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals . JAMA . 2003;291:210–215
  108. Everhart JE , Pettitt DJ , Knowler WC , et al.   Medial arterial calcification and its association with mortality and complications of diabetes . Diabetologia . 1988;31:16–23
  109. Niskanen L , Siitonen O , Suhonen M , et al.   Medial artery calcification predicts cardiovascular mortality in patients with NIDDM . Diabetes Care . 1994;17:1252–1256
  110. Lehto S , Niskanen L , Suhonen M , et al.   Medial artery calcification. A neglected harbinger of cardiovascular complications in noninsulin-dependent diabetes mellitus . Arterioscler Thromb Vasc Biol . 1996;16:978–983
  111. London GM , Guerin AP , Marchais SJ , et al.   Arterial media calcification in end-stage renal disease (Impact on all-cause and cardiovascular mortality) . Nephrol Dial Transplant . 2003;18:1731–1740
  112. Schwarz U , Buzello M , Ritz E , et al.   Morphology of coronary atherosclerotic lesions in patients with end- stage renal failure . Nephrol Dial Transplant . 2000;15:218–223
  113. Kiel DP , Kauppila LI , Cupples LA , et al.   Bone loss and the progression of abdominal aortic calcification over a 25 year period (The Framingham Heart Study) . Calcif Tissue Int . 2001;68:271–276
  114. Schulz EE , Arfai K , Liu X , et al.   Aortic calcification and the risk of osteoporosis and fractures . J Clin Endocrinol Metab . 2004;89:4246–4253
  115. Braun J , Oldendorf M , Moshage W , et al.   Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients . Am J Kidney Dis . 1996;27:394–401
  116. Ejerblad S , Ericsson JL , Eriksson I . Arterial lesions of the radial artery in uraemic patients . Acta Chir Scand . 1979;145:415–428
  117. Russo D , Palmiero G , DeBlasio AP , et al.   Coronary artery calcification in patients with CRF not undergoing dialysis . Am J Kidney Dis . 2004;44:1024–1030
  118. Kramer H , Toto R , Peshock R , et al.   Association between chronic kidney disease and coronary artery calcification (The Dallas Heart Study) . J Am Soc Nephrol . 2005;16:507–513
  119. Qunibi WY , Abouzahr F , Mizani MR , et al.   Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes . Kidney Int . 2005;68:271–277
  120. Kramer H , Jacobs DR , Bild D , et al.   Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis . Hypertension . 2005;46:38–43
  121. Pollak VE , Schneider AF , Freund G , et al.   Chronic renal disease with secondary hyperparathyroidism . Arch Intern Med . 1959;103:200–218
  122. Yoshida M , Takamatsu J , Yoshida S , et al.   Scores of coronary calcification determined by electron beam computed tomography are closely related to the extent of diabetes-specific complications . Horm Metab Res . 1999;31:558–563
  123. Olson JC , Edmundowicz D , Becker DJ , et al.   Coronary calcium in adults with type 1 diabetes (A stronger correlate of clinical coronary artery disease in men than in women) . Diabetes . 2000;49:1571–1578
  124. Colhoun HM , Rubens MB , Underwood SR , et al.   The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification . J Am Coll Cardiol . 2000;36:2160–2167
  125. Valabhji J , McColl AJ , Richmond W , et al.   Total antioxidant status and coronary artery calcification in type 1 diabetes . Diabetes Care . 2001;24:1608–1613
  126. Wagenknecht LE , Bowden DW , Carr JJ , et al.   Familial aggregation of coronary artery calcium in families with type 2 diabetes . Diabetes . 2001;50:861–866
  127. Yamagami K , Hosoi M , Yamamoto T , et al.   Coronary arterial calcification is associated with albuminuria in type 2 diabetic patient . Diabetes Obes Metab . 2005;7:390–396
  128. Freedman BI , Langefeld CD , Lohman KK , et al.   Relationship between albuminuria and cardiovascular disease in type 2 diabetes . J Am Soc Nephrol . 2005;16:2156–2161
  129. Mehrotra R , Budoff M , Hokanson JE , et al.   Progression of coronary artery calcification in diabetic patients with and without chronic kidney disease . Kidney Int . 2005;68:1258–1266
  130. Spiegel DM , Raggi P , Mehta R , et al.   Coronary and aortic calcifications in patients new to dialysis . Hemodialysis Int . 2004;2004:265–272
  131. Arad Y , Spadaro LA , Roth M , et al.   Serum concentrations of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomographic study . Coron Artery Dis . 1998;9:513–518
  132. Doherty TM , Tang W , Dascalos S , et al.   Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography . Circulation . 1997;96:1477–1481
  133. Watson KE , Abrolat ML , Malone L , et al.   Active serum vitamin D levels are inversely correlated with coronary calcification . Circulation . 1997;96:1755–1760
  134. Giachelli CM . Vascular calcification mechanisms . J Am Soc Nephrol . 2004;15:2959–2964
  135. Shioi A , Nishizawa Y , Jono S , et al.   Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells . Arterioscler Thromb Vasc Biol . 1995;15:2003–2009
  136. Chen NX , O’Neill KD , Duan D , et al.   Phosphorus and uremic serum upregulate osteopontin expression in vascular smooth muscle cells . Kidney Int . 2002;62:1724–1731
  137. Jono S , Nishizawa Y , Shioi A , et al.   Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells . Arterioscler Thromb Vasc Biol . 1997;17:1135–1142
  138. Huang Z , Li J , Jiang Z , et al.   Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells . J Cardiovasc Pharmacol . 2003;42:89–97
  139. Shao JS , Cheng SL , Charlton-Kachigian N , et al.   Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice . J Biol Chem . 2003;278:50195–50202
  140. London GM , Marty C , Marchais SJ , et al.   Arterial calcifications and bone histomorphometry in end-stage renal disease . J Am Soc Nephrol . 2004;15:1943–1951
  141. Ketteler M , Wanner C , Metzger T , et al.   Deficiencies of calcium-regulatory-proteins in dialysis patients (A novel concept of cardiovascular calcification in uremia) . Kidney Int . 2003;63:S84–S87
  142. Moe SM , Reslerova M , Ketteler M , et al.   Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD) . Kidney Int . 2005;67:2295–2304
  143. Schafer C , Heiss A , Schwarz A , et al.   The serum protein alpha-2 Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification . J Clin Invest . 2003;112:357–366
  144. Reynolds JL , Skepper JN , McNair R , et al.   Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification . J Am Soc Nephrol . 2005;16:2920–2930
  145. Mehrotra R , Westenfeld R , Christenson P , et al.   Serum fetuin-A in nondialyzed patients with diabetic nephropathy (Relationship with coronary artery calcification) . Kidney Int . 2005;67:1070–1077
  146. Kausz AT , Khan SS , Abichandani R , et al.   Management of patients with chronic renal insufficiency in the Northeastern United States . J Am Soc Nephrol . 2001;12:1501–1507
  147. Winkelmayer WC , Levin R , Avorn J . The nephrologist’s role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease . Kidney Int . 2003;63:1836–1842
  148. Nitta K , Akiba T , Suzuki H , et al.   Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis . Am J Kidney Dis . 2004;44:680–688

 Supported by a grant from the National Center for Research Resources (NCRR, NIH), RR18298-01 A1 for Rajnish Mehrotra and grant M01-RR00425 from the NCRR, NIH, for the General Clinical Research Center (GCRC) located at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Additional support has been provided by Clinical Research Feasibility Funds from the GCRC at Harbor-UCLA and Genzyme Pharmaceuticals.

PII: S1051-2276(06)00007-0

doi: 10.1053/j.jrn.2006.01.006

Journal of Renal Nutrition
Volume 16, Issue 2 , Pages 100-118 , April 2006

Article Tools

* Image Usage & Resolution